OrbusNeich Announces Schedule of Events at TCT 2017
Hong Kong (ots/PRNewswire) - - Program to include late-breaking presentation of REDUCE clinical trial - Data on more than 5,000 patients to be presented OrbusNeich, a global company specialising in the provision of life-changing vascular solutions, has today announced a schedule of events at the 29th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, ...